主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PTGX
#1031
Protagonist Therapeutics, Inc
92.080
0
+6.88%
版块:
基础:
利润货币:
日范围
年范围
日变化
+6.88%
每月变动
+11.68%
6个月变化
+22.56%
年变化
+22.56%
前一天收盘价
86.150
0
Open
92.210
0
Bid
Ask
Low
92.080
0
High
92.220
0
交易量
152
市场
股票
医疗保健
PTGX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
新闻
Protagonist TherapeuticsQ4每股收益及营收逊于预期
Protagonist Therapeutics earnings missed by $0.35, revenue fell short of estimates
Citizens上调Protagonist Therapeutics目标价,看好药物获批前景
Citizens raises Protagonist Therapeutics stock price target on drug approvals
Protagonist Therapeutics董事Williams出售价值148万美元股票
Protagonist Therapeutics director Williams sells $1.48 million in shares
Protagonist Therapeutics董事出售价值167万美元股票
Protagonist Therapeutics director sells $1.67 million in shares
2026年值得关注的顶级生物科技股,据Truist证券
Top Biotech Stocks to Watch in 2026, According to Truist
Protagonist Therapeutics股票目标价从80美元上调至117美元
Protagonist Therapeutics stock price target raised to $117 from $80 at H.C. Wainwright